Oxolamine citrate
CAS No. 1949-20-8
Oxolamine citrate( Oxalamine Citrate | Oxalamine Citrate salt )
Catalog No. M13049 CAS No. 1949-20-8
Oxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.
Oxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
200MG | 28 | In Stock |
|
500MG | 38 | In Stock |
|
1G | 45 | In Stock |
|
Biological Information
-
Product NameOxolamine citrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.
-
DescriptionOxolamine is a cough suppressant that is available as a generic drug in many jurisdictions.
-
In Vitro——
-
In Vivo——
-
SynonymsOxalamine Citrate | Oxalamine Citrate salt
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number1949-20-8
-
Formula Weight437.44
-
Molecular FormulaC14H19N3O·C6H8O7
-
Purity>98% (HPLC)
-
SolubilityWater: 10 mM
-
SMILESCCN(CC)CCC1=NC(C2=CC=CC=C2)=NO1.OC(C(O)=O)(CC(O)=O)CC(O)=O
-
Chemical NameN,N-Diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine citrate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ceyhan BB, Karakurt S. Respir Med. 2002 Jan;96(1):61-3.
molnova catalog
related products
-
Itaconic anhydride
Itaconic anhydride
-
Gastrin-Releasing Pe...
Gastrin-releasing peptide is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function. The post-ganglionic fibers of the vagus nerve that innervate the G cells of the stomach release GRP, which stimulates the G cells to release gastrin.
-
Malonic acid
Malonic acid (propanedioic acid) is the archetypal example of a competitive inhibitor: it acts against succinate dehydrogenase (complex II) in the respiratory electron transport chain. Malonic acid is found to be associated with malonyl-CoA decarboxylase deficiency which is an inborn error of metabolism.